TME Pharma N.V.: Half-yearly Report on the Liquidity Contract With Invest Securities
BERLIN--(BUSINESS WIRE)--Regulatory News: TME Pharma N.V. (Euronext Growth Paris: ALTME), a biotechnology company focused on developing novel therapies for treatment of cancer by targeting the…